Japan's aging population. Implications for healthcare

Adam James Oliver, Naoki Ikegami, Shunya Ikeda

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In the early years of the next century, the Japanese population may well become the oldest in the world. The Japanese government's concentration on post-World War II economic expansion meant that the goverment only fully woke up to the financial implications of having a large elderly population when oil prices were raised in the 1970s, highlighting Japan's economic dependence on global markets. This article explains the process by which policy regarding Japan's elderly developed both before and after these oil price increases. The measures of healthcare cost containment that the government introduced in response to the increased financial pressure are described, with a particular focus on pharmaceuticals. This article shows that the government has achieved a degree of success in terms of containing pharmaceutical costs, but that future effects on the quality of healthcare are uncertain. Ultimately, a wider application of a per diem fee in place of the prevalent fee-for-service system, and the realisation of plans to improve the social service infrastructure, would be the best path for policy to follow.

Original languageEnglish
Pages (from-to)306-318
Number of pages13
JournalPharmacoEconomics
Volume11
Issue number4
Publication statusPublished - 1997

Fingerprint

Japan
Delivery of Health Care
Oils
Economics
Population
Fee-for-Service Plans
World War II
Fees and Charges
Cost Control
Quality of Health Care
Social Work
Pharmaceutical Preparations
Health Care Costs
Pressure
Costs and Cost Analysis

ASJC Scopus subject areas

  • Pharmacology
  • Medicine (miscellaneous)

Cite this

Oliver, A. J., Ikegami, N., & Ikeda, S. (1997). Japan's aging population. Implications for healthcare. PharmacoEconomics, 11(4), 306-318.

Japan's aging population. Implications for healthcare. / Oliver, Adam James; Ikegami, Naoki; Ikeda, Shunya.

In: PharmacoEconomics, Vol. 11, No. 4, 1997, p. 306-318.

Research output: Contribution to journalArticle

Oliver, AJ, Ikegami, N & Ikeda, S 1997, 'Japan's aging population. Implications for healthcare', PharmacoEconomics, vol. 11, no. 4, pp. 306-318.
Oliver AJ, Ikegami N, Ikeda S. Japan's aging population. Implications for healthcare. PharmacoEconomics. 1997;11(4):306-318.
Oliver, Adam James ; Ikegami, Naoki ; Ikeda, Shunya. / Japan's aging population. Implications for healthcare. In: PharmacoEconomics. 1997 ; Vol. 11, No. 4. pp. 306-318.
@article{d0f6038673504e5bb6073c61389adcdb,
title = "Japan's aging population. Implications for healthcare",
abstract = "In the early years of the next century, the Japanese population may well become the oldest in the world. The Japanese government's concentration on post-World War II economic expansion meant that the goverment only fully woke up to the financial implications of having a large elderly population when oil prices were raised in the 1970s, highlighting Japan's economic dependence on global markets. This article explains the process by which policy regarding Japan's elderly developed both before and after these oil price increases. The measures of healthcare cost containment that the government introduced in response to the increased financial pressure are described, with a particular focus on pharmaceuticals. This article shows that the government has achieved a degree of success in terms of containing pharmaceutical costs, but that future effects on the quality of healthcare are uncertain. Ultimately, a wider application of a per diem fee in place of the prevalent fee-for-service system, and the realisation of plans to improve the social service infrastructure, would be the best path for policy to follow.",
author = "Oliver, {Adam James} and Naoki Ikegami and Shunya Ikeda",
year = "1997",
language = "English",
volume = "11",
pages = "306--318",
journal = "PharmacoEconomics",
issn = "1170-7690",
publisher = "Adis International Ltd",
number = "4",

}

TY - JOUR

T1 - Japan's aging population. Implications for healthcare

AU - Oliver, Adam James

AU - Ikegami, Naoki

AU - Ikeda, Shunya

PY - 1997

Y1 - 1997

N2 - In the early years of the next century, the Japanese population may well become the oldest in the world. The Japanese government's concentration on post-World War II economic expansion meant that the goverment only fully woke up to the financial implications of having a large elderly population when oil prices were raised in the 1970s, highlighting Japan's economic dependence on global markets. This article explains the process by which policy regarding Japan's elderly developed both before and after these oil price increases. The measures of healthcare cost containment that the government introduced in response to the increased financial pressure are described, with a particular focus on pharmaceuticals. This article shows that the government has achieved a degree of success in terms of containing pharmaceutical costs, but that future effects on the quality of healthcare are uncertain. Ultimately, a wider application of a per diem fee in place of the prevalent fee-for-service system, and the realisation of plans to improve the social service infrastructure, would be the best path for policy to follow.

AB - In the early years of the next century, the Japanese population may well become the oldest in the world. The Japanese government's concentration on post-World War II economic expansion meant that the goverment only fully woke up to the financial implications of having a large elderly population when oil prices were raised in the 1970s, highlighting Japan's economic dependence on global markets. This article explains the process by which policy regarding Japan's elderly developed both before and after these oil price increases. The measures of healthcare cost containment that the government introduced in response to the increased financial pressure are described, with a particular focus on pharmaceuticals. This article shows that the government has achieved a degree of success in terms of containing pharmaceutical costs, but that future effects on the quality of healthcare are uncertain. Ultimately, a wider application of a per diem fee in place of the prevalent fee-for-service system, and the realisation of plans to improve the social service infrastructure, would be the best path for policy to follow.

UR - http://www.scopus.com/inward/record.url?scp=0030893509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030893509&partnerID=8YFLogxK

M3 - Article

C2 - 10172965

AN - SCOPUS:0030893509

VL - 11

SP - 306

EP - 318

JO - PharmacoEconomics

JF - PharmacoEconomics

SN - 1170-7690

IS - 4

ER -